Therapeutic modalities in symptomatic intracranial arterial occlusive disease

References

• Gorelick PB. Distribution of atherosclerotic cerebrovascular lesions. Effects of age, race, and sex. Stroke 1993; 24: 116–119
   Web of Science ®Google Scholar
• Lutsep HL. Symptomatic intracranial stenosis: Best medical treatment vs. intracranial stenting. Curr Opin Neurol 2009; 22: 69–74
   PubMed Web of Science ®Google Scholar
• Mazighi M, Tanasescu R, Ducrocq X, et al. Prospective study ofsymptomatic atherothrombotic intracranial stenoses: The GESICA Study. Neurology 2006; 66: 1187–1191
   PubMed Web of Science ®Google Scholar
• Hass WK, Fields WS, North RR, et al. Joint study of extracranialarterial occlusion. II. Arteriography, techniques, sites, and complications. JAMA 1968; 203: 961–968
   PubMed Web of Science ®Google Scholar
• Bogousslavsky J, van Melle G, Regli F. The Lausanne Stroke Registry: Analysis of 1,000 consecutive patients with first stroke. Stroke 1988; 19: 1083–1092
   PubMed Web of Science ®Google Scholar
• Qureshi Al, Safdar K, Patel M, et al. Stroke in young black patients. Risk factors, subtypes, and prognosis. Stroke 1995; 26: 1995–1998
   PubMed Web of Science ®Google Scholar
• Craig DR, Meguro K, Watridge C, et al. Intracranial internal carotid artery stenosis. Stroke 1982; 13: 825–828
   PubMed Web of Science ®Google Scholar
• Sacco RL, Kargman DE, Gu Q, et al. Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study. Stroke 1995; 26: 14–20
   PubMed Web of Science ®Google Scholar
• Akins PT, Pilgram TK, Cross DT, 3rd, et al. Natural history of stenosis from intracranial atherosclerosis by serial angiography. Stroke 1998; 29: 433–438
   PubMed Web of Science ®Google Scholar
• Thijs VN, Albers GW. Symptomatic intracranial atherosclerosis: Outcome of patients who fail antithrombotic therapy. Neurology 2000; 55: 490–497
   PubMed Web of Science ®Google Scholar
• Barnett Hi, Fox A, Hachinski V, et al. Further conclusions from the extracranial—intracranial bypass trial. Surg Neurol 1986; 26: 227–235
   PubMedGoogle Scholar
• Failure of extracranial—intracranial arterial bypass to reduce the risk of ischemic stroke. Results of an international randomized trial. The EC/IC Bypass Study Group. N Engl J Med 1985; 313: 1191–1200
   PubMed Web of Science ®Google Scholar
• Bogousslavsky J, Barnett Hi, Fox Ai, et al. Atherosclerotic disease of the middle cerebral artery. Stroke 1986; 17: 1112–1120
   PubMed Web of Science ®Google Scholar
• Pessin MS, Gorelick PB, Kwan ES, et al. Basilar artery stenosis: Middle and distal segments. Neurology 1987; 37: 1742–1746
   PubMed Web of Science ®Google Scholar
• Chimowitz MI, Kokkinos J, Strong J, et al. The Warfarin—Aspirin Symptomatic Intracranial Disease Study. Neurology 1995; 45: 1488–1493
   PubMed Web of Science ®Google Scholar
• Chimowitz MI. Antithrombotic therapy for atherosclerotic intra-cranial arterial stenosis. Adv Neurol 2003; 92: 271–274
   PubMedGoogle Scholar
• Chimowitz MI, Lynn MJ, Howlett-Smith H, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005; 352: 1305–1316
   PubMed Web of Science ®Google Scholar
• Kasner SE, Lynn MJ, Chimowitz MI, et al. Warfarin vs aspirin for symptomatic intracranial stenosis: Subgroup analyses from WASID. Neurology 2006; 67: 1275–1278
   PubMed Web of Science ®Google Scholar
• Amarenco P, Bogousslavsky J, Callahan A, 3rd, et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006; 355: 549–559
   PubMed Web of Science ®Google Scholar
• Amarenco P, Lavallee P, Touboul PI Stroke prevention, blood cholesterol, and statins. Lancet Neurol 2004; 3: 271–278
   PubMed Web of Science ®Google Scholar
• Chapman N, Huxley R, Anderson C, et al. Effects of a perindopril- based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: The PROGRESS trial. Stroke 2004; 35: 116–121
   PubMed Web of Science ®Google Scholar
• Lonn E, Yusuf S, Dzavik V, et al. Effects of ramipril and vitamin e on atherosclerosis: The Study to Evaluate Carotid Ultrasound changes in patients treated with Ramipril and vitamin E (SECURE). Circulation 2001; 103: 919–925
   PubMed Web of Science ®Google Scholar
• Hamai M, Iwai M, Ide A, et al. Comparison of inhibitory action ofcandesartan and enalapril on brain ischemia through inhibition of oxidative stress. Neuropharmacology 2006; 51: 822–828
   PubMed Web of Science ®Google Scholar
• Thone-Reineke C, Steckelings UM, Unger T. Angiotensin receptor blockers and cerebral protection in stroke. J Hypertens Suppl 2006; 24: S115—S121
   PubMedGoogle Scholar
• Bosel J, Gandor F, Harms C, et al. Neuroprotective effects of atorvastatin against glutamate-induced excitotoxicity in primary cortical neurones. J Neurochem 2005; 92: 1386–1398
   PubMed Web of Science ®Google Scholar
• Endres M. Statins and stroke. J Cereb Blood Flow Metab 2005; 25: 1093–1110
   PubMed Web of Science ®Google Scholar
• Asahi M, Huang Z, Thomas S, et al. Protective effects of statins involving both eNOS and tPA in focal cerebral ischemia. J Cereb Blood Flow Metab 2005; 25: 722–729
   PubMed Web of Science ®Google Scholar
• Chen J, Zhang ZG, Li Y, et al. Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke. Ann Neurol 2003; 53: 743–751
   PubMed Web of Science ®Google Scholar
• Kasner SE, Chimowitz MI, Lynn MJ, et al. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation 2006; 113: 555–563
   PubMed Web of Science ®Google Scholar
• Derdeyn CP, Chimowitz MI. Angioplasty and stenting for atherosclerotic intracranial stenosis: Rationale for a randomized clinical trial. Neuroimaging Clin N Am 2007; 17: 355–363
   PubMed Web of Science ®Google Scholar
• Sundt TM, Jr, Smith HC, Campbell JK, et al. Transluminal angioplasty for basilar artery stenosis. Mayo Clin Proc 1980; 55: 673–680
   PubMed Web of Science ®Google Scholar
• Clark WM, Barnwell SL, Nesbit G, et al. Safety and efficacy of percutaneous transluminal angioplasty for intracranial athero-sclerotic stenosis. Stroke 1995; 26: 1200–1204
   PubMed Web of Science ®Google Scholar
• Touho H. Percutaneous transluminal angioplasty in the treatment of atherosclerotic disease of the anterior cerebral circulation and hemodynamic evaluation. J Neurosurg 1995; 82: 953–960
   PubMed Web of Science ®Google Scholar
• Marks MP, Wojak JC, Al-Ali F, et al. Angioplasty for sympto-matic intracranial stenosis: Clinical outcome. Stroke 2006; 37: 1016–1020
   PubMed Web of Science ®Google Scholar
• Lylyk P, Cohen JE, Ceratto R, et al. Angioplasty and stent placement in intracranial atherosclerotic stenoses and dissections. AJNR Am J Neuroradiol 2002; 23: 430–436
   PubMed Web of Science ®Google Scholar
• Lylyk P, Cohen JE, Ferrario A, et al. Partially clipped intracranial aneurysm obliterated with combined stent and coil implantation. J Endovasc Ther 2002; 9: 160–164
   PubMed Web of Science ®Google Scholar
• Lylyk P, Cohen JE, Ceratto R, et al. Combined endovascular treatment of dissecting vertebral artery aneurysms by using stents and coils. J Neurosurg 2001; 94: 427–432
   PubMed Web of Science ®Google Scholar
• Phatouros CC, Lefler JE, Higashida RT, et al. Primary stenting for high-grade basilar artery stenosis. AJNR Am J Neuroradiol 2000; 21: 1744–1749
   PubMed Web of Science ®Google Scholar
• Al-Mubarak N, Gomez CR, Vitek H, et al. Stenting of symptomatic stenosis of the intracranial internal carotid artery. AJNR Am J Neuroradiol 1998; 19: 1949–1951
   PubMed Web of Science ®Google Scholar
• Al-Mubarak N, Roubin GS, Gomez CR, et al. Carotid artery stenting in patients with high neurologic risks. Am J Cardiol 1999; 83: 1411–1413
   PubMed Web of Science ®Google Scholar
• Gomez CR, Misra VK, Campbell MS, et al. Elective stenting of symptomatic middle cerebral artery stenosis. AJNR Am J Neuroradiol 2000; 21: 971–973
   PubMed Web of Science ®Google Scholar
• Gomez CR, Misra VK, Liu MW, et al. Elective stenting of symptomatic basilar artery stenosis. Stroke 2000; 31: 95–99
   PubMed Web of Science ®Google Scholar
• Roubin GS, New G, Iyer SS, et al. Immediate and late clinical outcomes of carotid artery stenting in patients with symptomatic and asymptomatic carotid artery stenosis: A 5-year prospective analysis. Circulation 2001; 103: 532–537
   PubMed Web of Science ®Google Scholar
• Gupta R, Al-Ali F, Thomas Ai, et al. Safety, feasibility, and short-term follow-up of drug-eluting stent placement in the intracranial and extracranial circulation. Stroke 2006; 37: 2562–2566
   PubMed Web of Science ®Google Scholar
• Hahnel S, Ringleb P, Hartmann M. Treatment of intracranial stenoses using the neuroform stent system: Initial experience in five cases. Neuroradiology 2006; 48: 479–485
   PubMed Web of Science ®Google Scholar
• Jiang WJ, Xu XT, Jin M, et al. Apollo stent for symptomatic atherosclerotic intracranial stenosis: Study results. AJNR Am J Neuroradiol 2007; 28: 830–834
   PubMed Web of Science ®Google Scholar
• Qureshi Al, Kirmani JF, Hussein HM, et al. Early and intermediate-term outcomes with drug-eluting stents in high-risk patients with symptomatic intracranial stenosis. Neurosurgery 2006; 59: 1044–1051
   PubMed Web of Science ®Google Scholar
• Suh DC, Kim JK, Choi JW, et al. Intracranial stenting of severe symptomatic intracranial stenosis: Results of 100 consecutive patients. AJNR Am J Neuroradiol 2008; 29: 781–785
   PubMed Web of Science ®Google Scholar
• Zaidat OO, Klucznik R, Alexander MJ, et al. The NIH registry on use of the wingspan stent for symptomatic 70-99% intracranial arterial stenosis. Neurology 2008; 70: 1518–1524
   PubMed Web of Science ®Google Scholar
• Levy El, Turk AS, Albuquerque FC, et al. Wingspan in-stent restenosis and thrombosis: Incidence, clinical presentation, and management. Neurosurgery 2007; 61: 641 650
   Google Scholar
• Hartmann M, Jansen O. Angioplasty and stenting of intracranial stenosis. Curr Opin Neurol 2005; 18: 39–45
   PubMed Web of Science ®Google Scholar
• Jovin TG, Gupta R, Horowitz MB. Management of symptomatic intracranial atherosclerotic disease. Curr Cardiol Rep 2007; 9: 32–40
   PubMedGoogle Scholar
• Fiorella D, Levy El, Turk AS, et al. US multicenter experience with the Wingspan stent system for the treatment of intracranial atheromatous disease: Periprocedural results. Stroke 2007; 38: 881–887
   PubMed Web of Science ®Google Scholar
• Bose A, Hartmann M, Henkes H, et al. A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses: The Wingspan study. Stroke 2007; 38: 1531–1537
   PubMed Web of Science ®Google Scholar
• Turk AS, Levy El, Albuquerque FC, et al. Influence of patient ageand stenosis location on wingspan in-stent restenosis. AJNR Am J Neuroradiol 2008; 29: 23–27
   PubMed Web of Science ®Google Scholar
• Kurre W, Berkefeld J, Sitzer M, et al. Treatment of symptomatic high-grade intracranial stenoses with the balloon-expandable Pharos stent: Initial experience. Neuroradiology 2008; 50: 701–708
   PubMed Web of Science ®Google Scholar
• SSYLVIA Study Investigators. Stenting of symptomatic athero-sclerotic lesions in the vertebral or intracranial arteries (SSYLVIA): Study results. Stroke 2004; 35: 1388–1392
   PubMed Web of Science ®Google Scholar
• Chimowitz MI. Angioplasty or stenting is not appropriate as first-line treatment of intracranial stenosis. Arch Neurol 2001; 58: 1690–1692
   PubMedGoogle Scholar